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THE POSSIBLE   ROLE OF SOLUBLE MATERIAL FROM MACROPHAGES IN   CELL 
MEDIATED IMMUNITY IN PULMONARY TUBERCULOSIS 
RAJI   SWAMY,   R. PRABHAKAR, AND P.R. NARAYANAN 
Summary : Lymphocytes from pulmonary tuberculosis patients and healthy controls showed identical 
proliferative responses to mitogen (PHA) and antigen (PPD) on Day ‘O’ (DO), Day-2 (D2) and 
Day-7 (D7) of culture. Also, there was no suppression of PHA induced lymphocyte proliferation in 
the presence of culture supernatants of pulmonary tuberculosis patient’s mononuclear cells. 
Introduction 
Immunosuppression by macrophages has 
been reported in tuberculosis (Elinor, 1978) 
and sarcoidosis (Goodwin, 1977, 1979). Though 
the precise mechanism of the immunosuppres-
sion is poorly understood, several macrophage 
mediators have been identified, such as thymi-
dine (Opitz et al., 1975), Prostaglandins (Mor-
ley, 1974), Oxygen metabolites (Grey et al. 
1979), Arginase (Kung et al., 1977), Comple-
ment components (Allison, 1978). The speci-
ficity and in vivo role of these mediators in 
immunosuppression are yet to be determined. 
While investigating the immunosuppression 
in chronic fungal infection, Stobo (1977) has 
shown that patients’ macrophages liberated, 
in vitro, a soluble material (SM) capable of 
inhibiting the blastogenic response of normal 
T-cell to mitogens and antigens. However, 
not all T-cells were equally susceptible to its 
suppressive effect. Only the short-lived, low-
density T-cells in fresh peripheral blood mono-
nuclear cells (PBMC) could be suppressed by 
the SM. Hence, incubation of PBMC for 
seven days in culture fluid could result in a 
functional deletion of the short lived low den-
sity T-cells and yielded high density T-cells 
whose reactivity could not be suppressed by 
SM. 
In this report, we have looked for the possible 
existence of a similar suppressive mechanism in 
pulmonary tuberculosis. 
Material and Methods 
Subjects : The patient group consisted of 
12 pretreatment pulmonary tuberculosis pa-
tients admitted to the controlled clinical trial 
of the Tuberculosis Research Centre. The 
sputum of all the patients was positive by smear 
nd culture for Mycobacterium tuberculosis. a  
Twelve healthy blood bank volunteers served 
as controls. 
Twenty millilitres of blood was drawn from 
each individual in a heparinised container and 
PBMC separated on Ficoll hypaque (Boyum, 
1968). The cells were washed three times with 
Hank’s balanced salt solution (HBSS) and 
suspended at a concentration of 0.75 X 106 
cells per ml. in RPMI-1640, containing 2 mM 
Glutamine, 80 ug/ml gentamycin and 10% 
pooled heat-inactivated human AB serum 
(CRPMI) and placed in plastic tissue culture 
flasks at 37°C in a humidified atmosphere of 
95% air and 5% CO2. On O, 2 and 7 days the 
cultures were terminated by centrifugation. 
The cells were washed, resuspended at 0.5x 
106 cells per ml in fresh CRPMI and a lym-
phocyte proliferation test was performed. 
Triplicates of 0.2 ml of cells were placed in a 96 
well microculture plate and the cultures were 
stimulated with either 5 ug/ml Phytohemagglu-
tinin (PHA) or 50 ug/ml PPD and maintained 
for 4 and 6 days, respectively. Eighteen hours 
before harvesting, 1 uCi 3H-thymidine was 
added to each well and the cells were harvested 
in a semi-automated cell harvester on fibre 
glass filter paper discs. Radioactivity of the 
discs was measured in a liquid scintillation 
counter. The results were expressed as stimula-
tion index (S.I.). 
Mean log count stimulated culture 
S.I.= 
Mean long count control culture 
In addition, the supernatant culture fluid 
obtained on day-2 and day-7 of the PBMC 
was added in a final concentration of 25% to 
2 normal PBMC suspended in CRPMI and the 
PHA reactivity of this mixture tested. Stimu-
lation index was calculated as described above. 
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Results and Discussion 
Stimulation Index for PHA and PPD induced 
lymphocyte proliferation on day O, 2 and 1 
PBMC were incubated for seven days in 
plastic tissue culture flasks and lymphocyte 
proliferation tests were done on days 0, 2 and 7. 
The results of these tests are presented in Table 1. 
Increasing duration of incubation did not result 
in increased stimulation of the patients’ lympho-
cytes. In Stobo’s work (1977) there was an 
eight-fold rise in the proliferative response of 
patients’ lymphocytes on day 7 which was 
attributed to the functional deletion of low 
density, short—lived T-lymphocytes. These 
lymphocytes which are susceptible to the sup-
pressive SM liberated by the patients’ macro-
phages were responsible for the inhibition of 
lymphocyte proliferation on day ‘O’. Since 
lymphocytes from tuberculosis patients have 
not shown any enhancement of stimulation, 
either by antigen or by mitogen, it may be 
concluded that tuberculous macrophages do 
not produce the suppressive material as macro-
phages from chronic fungal infection do. The 
results of the second experiment also suggest 
the same. 
Stimulation Index for normal PBMC in the 
presence of 25% culture supernatant of control 
and tuberculous PBMC and 5 ug/ml PHA 
A lymphocyte proliferation test for PHA 
(5ug/ml) was done on two healthy blood bank 
volunteers’ lymphocytes in the presence of 25 % 
culture supernatant collected on day 2 and day 7 
of control and tuberculous PBMC cultures. 
The results are shown in Table 2. Tuberculous 
PBMC supernatant have failed to show any 
TABLE 1 
Mean + S.D. of Stimulation Index of lymphocytes stimulated with 5 ug/ml PHA or 50 ug/ml PPD on Day   ‘O’, 2 
and 7 of culture 
 
 Control (12)   Patient (12)  
Days  (PHA)  (PPD)  (PHA)  (PPD)  
D— 0  1.53 ± 0.09  1.12 ± 0.11  1.53 ± 0.17  1.13 ± 0.12  
D— 2  1.56 ± 0.12  1.13 ± 0.08  1.51  ± 0.13  1.10 ± 0.11  
D— 7  1.37 ± 0.13  1.16 ± 0.15  1.37 ± 0.18  1.18 ± 0.18  
N.B. ; Numbers  in  parantheses  indicate number of individuals tested. 
TABLE 2 
Mean + S.D. of Stimulation Index for PHA (5 ug/ml) induced lymphocyte proliferation in the presence of 25 % 
culture supernatants on two normal lymphocytes 
 
Control  SN (10)  Patient  SN (10)  SN  
No. Day 2  Day 7  Day 2  Day 7  0%  
1. 1.37 ± 0.05  1.39 ± 0.09  1.33 ± 0.11  1.38 ± 0.06  1.33  
2. 1.33 ± 0.09  1.32 ± 0.06  1.26 ± 0.09  1.32 ± 0.09  1.28  
N.B. : Numbers in parantheses indicate number of individuals tested. 
SN = Supernatant. 
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suppression of the SI of normal lymphocytes. 
The supernatant from the control group also 
gave similar results. 
To conclude, the present results suggest 
that tuberculous macrophages may not be 
producing suppressive soluble material as was 
reported for chronic fungal infection. Accord-
ing to Ellner (1978), circulating suppressor 
monocytes are responsible for the diminished 
response to PPD induced lymphocyte blast 
transformation in low responders in tubercu-
losis and was able to show a 24-fold enhance-
ment of lymphocyte proliferation in these 
patients by depletion of adherent monocytes. 
Further, it was also observed that this effect 
could not be mediated through monocyte cell 
supernatants. 
Thus, the results of the experiment des-
cribed above suggest that the possible approach 
to the defect in cell mediated immuity in tuber-
culosis could be studies related to evaluation 
of microbicidal properties of macrophages sti-
mulated with appropriate lymphokines. 
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